Project Details
Description
The study is intended to estimate the proportion and clinical management of people with type 2 diabetes having atherosclerotic cardiovascular diseases or who are at high risk to develop atherosclerotic cardiovascular diseases.
Participants will be asked to give information about their health. Partipants will continue normal way of life and will not get any medication other than those prescribed to them by the doctor.
The study will last for about 6 months.
Participants will be asked to give information about their health. Partipants will continue normal way of life and will not get any medication other than those prescribed to them by the doctor.
The study will last for about 6 months.
| Acronym | PACT-MEA |
|---|---|
| Status | Finished |
| Effective start/end date | 21/04/22 → 31/08/22 |
Collaborative partners
- Novo Nordisk Foundation (lead)
- Abu Dhabi Health Services Company
Keywords
- Glucose Metabolism Disorders
- Metabolic Diseases
- Endocrine System Diseases
- Arteriosclerosis
- Arterial Occlusive Diseases
- Vascular Diseases
- Cardiovascular Diseases
- Atherosclerosis
- Diabetes Mellitus
- Type 2 Diabetes Mellitus
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.